Government entities that oversee access to drugs in New Zealand are planning to adopt the aides and tools of artificial intelligence to accelerate operations and support decisions.
The Medicines and Medical Devices Authority in New Zealand and the Pharmac Agency (Pharmac) participated in the Microsoft Copilot pilot, which is a smart Chatbot that works with conversation materials.
Besides, MedSafe explores the use of other artificial intelligence tools “with the ability to manage large data groups and meet the requirements of the patient’s commercial and sensitive requirements.”
Chris James, director of the MedSafe Group, shared the most possible use of the Aerobic Organization in the Medicine List in a letter to the Assistant Minister of Health, David Simor, who recently wrote to them encouraged their adoption of artificial intelligence:
- Artificial intelligence to simplify the generation of the evaluation report, allowing Medasavi to provide information more quickly in the public domain;
- Amnesty International to assist side effects and directional assessments; and
- Artificial intelligence to help assess large information files as part of the analysis required to make decisions on new medical applications.
Meanwhile, Pharmac Paula Bennett Chairman told Seymour that their employees have begun to use artificial intelligence tools to help “processing complex information, analyzing large quantities of data, improving the clarity of technical content and accessing it.”
“These applications really help us to work quickly and effectively and will also have a role in supporting more transparency in decision -making,” assistant minister of health said in a separate message. Pharmac decides on pharmaceutical drugs and products for public financing.
“I think technology absorption greatly increases productivity and [I] See AL plays a role in Pharmac and MedSafe more efficient. The Minister of Health indicated in the media statement that finding efficiency in medical evaluation processes means that patients can reach the treatments they need faster.
The biggest context
The pressure to increase the dependence of Pharmac and Medsafe is part of the broader digital transformation of the New Zealand health system.
in 2025 budgetThe New Zealand government allocated $ 7 million ($ 4.1 million) to improve Parmac data and digital infrastructure.
MEDSAFE also strengthened the way to monitor the safety of medicine. For example, in 2023, I worked with the negative reactions control center for the development of A. A new digital system for collecting and storing harmful drug reaction reportsReplace its 60 -year -old database.
At the same time, in MEDSAFE The first record of controlled drugs In the country, which is expected to increase the efficiency of the pharmacy.
